• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Healthcare Realty Reports Fourth Quarter 2025 Results

    2/12/26 4:15:00 PM ET
    $HR
    Real Estate Investment Trusts
    Real Estate
    Get the next $HR alert in real time by email

    NASHVILLE, Tenn., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the fourth quarter ended December 31, 2025 and introduced full year 2026 guidance.

    "2025 represented a transformational year for Healthcare Realty," commented Peter Scott, the Company's President and Chief Executive Officer. "Our operational team delivered same-store growth that continues to exceed historical levels while our transactions team exceeded targets with $1.2 billion in dispositions at attractive pricing levels. We are encouraged by secular long-term trends driving demand for outpatient medical services, tenant space and assets across the country. We have strategically strengthened our corporate governance, leadership team and balance sheet over the past nine months, and I would like to thank the entire Healthcare Realty team for their strong efforts as we position the Company for sustainable long-term growth."

    FOURTH QUARTER 2025 HIGHLIGHTS

    • GAAP Net Income of $0.04 per share, NAREIT FFO of $0.36 per share, Normalized FFO of $0.40 per share, and FAD of $113.9 million (payout ratio of 75%)
    • Same store cash NOI growth of +5.5% was driven by tenant retention of 82.7% with +3.7% cash leasing spreads
    • Fourth quarter lease executions totaled 1.5 million square feet including 316,000 square feet of new lease executions
      • Sequential lease up of over 500 bps in redevelopment projects versus prior quarter
      • Significant leasing momentum in early 2026 with nearly 1 million square feet of new and renewal leases executed year-to-date
    • During the fourth quarter and through February, completed asset sales of $682 million, inclusive of one transaction expected to close later this month
    • Net Debt to Adjusted EBITDA of 5.4x
    • In December, Moody's Investors Service revised outlook to Stable and affirmed a Baa2 credit rating

    FULL YEAR 2025 HIGHLIGHTS

    • GAAP Net Loss of $0.71 per share, NAREIT FFO of $1.38 per share, Normalized FFO of $1.61 per share, and FAD of $448.3 million (payout ratio of 87%)
    • Same store cash NOI growth of +4.8% was driven by 103 basis points in occupancy gain and tenant retention of 81.5% with +3.1% cash leasing spreads
    • Full year lease executions totaled approximately 5.8 million square feet including 1.6 million square feet of new lease executions
    • During 2025 and through February 2026, completed asset sales of $1.2 billion, inclusive of one transaction expected to close later this month, through 34 separate transactions at a blended cap rate of 6.7%
    • Net Debt to Adjusted EBITDA was 5.4x at December 31, 2025, down from 6.1x at prior year end
    • Repaid approximately $650 million of term loans and $250 million of senior notes. Extended $1.5 billion revolver to mature in July 2030 (inclusive of extension options) and added 1 to 2 years of additional extension options on outstanding term loans
    • Reduced run-rate G&A expense by $10 million through cost saving implementations
    • Appointed Peter Scott as President & Chief Executive Officer, Daniel Gabbay as Chief Financial Officer and supplemented leadership team with experienced industry executives

    FOURTH QUARTER AND FULL YEAR 2025 RESULTS

     THREE MONTHS ENDED YEAR ENDED
     DECEMBER 31, 2025DECEMBER 31, 2024 DECEMBER 31, 2025DECEMBER 31, 2024
    (in thousands, except per share amounts)AMOUNTPER SHAREAMOUNTPER SHARE AMOUNTPER SHAREAMOUNTPER SHARE
    GAAP Net income (loss)$14,391 $0.04 $(106,846)$(0.31) $(246,071)$(0.71)$(654,485)$(1.81)
    NAREIT FFO, diluted$126,981 $0.36 $105,642 $0.30  $490,048 $1.38 $193,257 $0.52 
    Normalized FFO, diluted$142,147 $0.40 $143,414 $0.40  $568,946 $1.61 $576,785 $1.56 
                              

    LEASING ACTIVITY

    During the fourth quarter, the Company executed 292 new and renewal leases for 1.5 million square feet with a weighted average lease term of 6.2 years and average annual escalators of 3.0%.

    Key leasing highlights:

    • Memphis, TN. 166,000 square feet of renewals with our health system partner, Baptist Memorial Health, maintaining 100% occupancy across four on-campus medical office buildings
    • Austin, TX. 92,100 square feet of renewals with Baylor Scott & White Health in two fully occupied on-campus assets
    • Hartford, CT. 65,500 square feet of new leases with Hartford Health (A rated) expanding our existing relationship, which also resulted in a substantial credit upgrade from the former tenant, Prospect Health
    • Charlotte, NC. 15,500 square foot new lease with a leading multi-specialty healthcare provider aligned with Novant Health

    CAPITAL ALLOCATION

    Dispositions

    During the fourth quarter and through February, the Company successfully completed most of its previously identified dispositions for a total of $682 million, inclusive of one transaction expected to close later this month. A summary of the significant sale transactions is as follows:

    • Portfolio Sale/Various Markets. Completed strategic market exits of the El Paso, TX; Des Moines, IA; Fort Wayne, IN; Cincinnati, OH; Salt Lake City, UT; Las Vegas, NV; and Kokomo, IN MSAs with the sale of a 25-property portfolio for $348.9 million to a single private purchaser, reducing exposure to non-priority markets and further refining the Company's core operating portfolio
    • Phoenix, AZ. Disposed of two unaffiliated, off-campus properties to private market purchasers for $27.5 million. One asset was fully vacant at the time of the sale
    • Atlanta, GA. Opportunistic sale of one fully stabilized asset to the affiliated health system at a premium valuation of $21.9 million
    • Jacksonville, FL. Completed strategic market exit of the Jacksonville, FL MSA with the $18.6 million sale of two fully-leased MOBs at attractive market pricing

    Development and Redevelopment

    During the fourth quarter, the Company added five new redevelopments and made significant progress on its development and redevelopment pipeline, advancing several key projects across major markets. Highlights of new projects commenced include:

    • Houston, TX. Part of a two-MOB cluster in the growing Clear Lake submarket located between two major hospitals, HCA Houston Clear Lake and Houston Methodist Clear Lake. The $10.4 million redevelopment will transform the large user space layouts into modern, multi-tenant clinical suites
    • Denver, CO. A two-MOB cluster located in a rapidly growing submarket between UC Highlands Ranch hospital and Advent Health Littleton hospital. The $10.2 million redevelopment project will modernize the properties and deliver an expected return on investment through lease up of 31,000 square feet at strong rental rates

    Balance Sheet

    • Debt paydown from asset sales reduced Net Debt to Adjusted EBITDA to 5.4x. At year-end, the Company has approximately $1.4 billion of liquidity on the line of credit and cash on hand
    • In the fourth quarter, the Company fully repaid $542 million of term loans due in 2027
    • In January 2026, the Company repurchased 2.9 million shares of its common stock at an average price of $17.27 per share for a total of $50 million
    • In addition, on February 12, 2026, Healthcare Realty announced the establishment of its inaugural commercial paper program, with a total size of up to $600 million, further diversifying the Company's range of financing alternatives

    DIVIDEND

    The Board unanimously approved a common stock dividend in the amount of $0.24 per share to be paid on March 11, 2026, to Class A common stockholders of record on February 24, 2026. Additionally, the eligible holders of operating partnership units will receive a distribution of $0.24 per unit, equivalent to the Company's Class A common stock dividend.

    GUIDANCE

    The Company's 2026 per share estimated guidance ranges are as follows:

     ACTUAL2026 GUIDANCE
      2025 LOWHIGH
    Earnings per share$(0.71)$(0.05)$0.05 
    NAREIT FFO per share$1.38 $1.44 $1.50 
    Normalized FFO per share$1.61 $1.58 $1.64 
    Same Store Cash NOI growth 4.8% 3.5% 4.5%
              

    The 2026 annual guidance range reflects the Company's view of current and future market conditions, including assumptions with respect to rental rates, occupancy levels, interest rates, and operating and general and administrative expenses. The Company's guidance does not contemplate impacts from gains or losses from dispositions, potential impairments, or debt extinguishment costs, if any. The Company's guidance also does not include any future acquisitions, developments or share issuances or repurchases, other than as discussed in the detailed guidance assumptions on page 30 of the 4Q 2025 Supplemental. There can be no assurance that the Company's actual results will not be materially higher or lower than these expectations. If actual results or timing vary from these assumptions, the Company's expectations may change. See page 30 of the 4Q 2025 Supplemental for additional details and assumptions.

    EARNINGS CALL

    On Friday, February 13, 2026, at 9:00 a.m. Eastern Time, Healthcare Realty Trust has scheduled a conference call to discuss earnings results, quarterly activities, general operations of the Company and industry trends.

    Simultaneously, a webcast of the conference call will be available to interested parties at https://investors.healthcarerealty.com/corporate-profile/webcasts under the Investor Relations section. A webcast replay will be available following the call at the same address.

    Live Conference Call Access Details:

    • Domestic Dial-In Number: +1 800-715-9871 access code 4950066
    • All Other Locations: +1 646-307-1963 access code 4950066

    Replay Information:

    • Domestic Dial-In Number: +1 800-770-2030 access code 4950066
    • All Other Locations: +1 609-800-9909 access code 4950066

    ABOUT HEALTHCARE REALTY

    Healthcare Realty Trust Incorporated (NYSE:HR) is the largest public, pure-play owner, operator and developer of medical outpatient buildings in the United States.

    Additional information regarding the Company, including this quarter's operations, can be found at www.healthcarerealty.com. In addition to the historical information contained within, this press release contains certain forward-looking statements with respect to the Company. Forward-looking statements include all statements that do not relate solely to historical or current facts and can be identified by the use of words such as "may," "will," "expect," "believe," "anticipate," "target," "intend," "plan," "estimate," "project," "continue," "should," "could," "budget" and other comparable terms. These forward-looking statements are based on the Company's current plans, objectives, estimates, expectations and intentions and inherently involve significant risks and uncertainties. Such risks and uncertainties include, among other things, the following: the Company's expected results may not be achieved; risks related to future opportunities and plans for the Company, including the uncertainty of expected future financial performance and results of the Company; pandemics or other health crises; increases in interest rates; the availability and cost of capital at expected rates; competition for quality assets; negative developments in the operating results or financial condition of the Company's tenants, including, but not limited to, their ability to pay rent; the Company's ability to reposition or sell facilities with profitable results; the Company's ability to release space at similar rates as vacancies occur; the Company's ability to renew expiring leases; government regulations affecting tenants' Medicare and Medicaid reimbursement rates and operational requirements; unanticipated difficulties and/or expenditures relating to future acquisitions and developments; changes in rules or practices governing the Company's financial reporting; the Company may be required under purchase options to sell properties and may not be able to reinvest the proceeds from such sales at rates of return equal to the return received on the properties sold; uninsured or underinsured losses related to casualty or liability; the incurrence of impairment charges on its real estate properties or other assets; other legal and operational matters; and other risks and uncertainties affecting the Company, including those described from time to time under the caption "Risk Factors" and elsewhere in the Company's filings and reports with the SEC, including the Company's Annual Report on Form 10-K for the year ended December 31, 2024. Moreover, other risks and uncertainties of which the Company is not currently aware may also affect the Company's forward-looking statements and may cause actual results and the timing of events to differ materially from those anticipated. The forward-looking statements made in this communication are made only as of the date hereof or as of the dates indicated in the forward-looking statements, even if they are subsequently made available by the Company on its website or otherwise. The Company undertakes no obligation to update or supplement any forward-looking statements to reflect actual results, new information, future events, changes in its expectations or other circumstances that exist after the date as of which the forward-looking statements were made, except as required by law. Stockholders and investors are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in the Company's filings and reports, including, without limitation, estimates and projections regarding the performance of development projects the Company is pursuing. For a detailed discussion of the Company's risk factors, please refer to the Company's filings with the SEC, including this report and the Company's Annual Report on Form 10-K for the year ended December 31, 2024.

    Balance Sheet
    AMOUNTS IN THOUSANDS, EXCEPT PER SHARE DATA



    ASSETS     
     4Q 2025 3Q 2025 2Q 2025 1Q 2025 4Q 2024 
    Real estate properties     
    Land$1,060,254 $1,066,616 $1,105,231 $1,134,635 $1,143,468 
    Buildings and improvements 8,514,165  8,557,270  9,199,089  9,729,912  9,707,066 
    Lease intangibles 455,254  504,309  567,244  631,864  664,867 
    Personal property 7,056  6,854  6,944  9,938  9,909 
    Investment in financing receivables, net 123,249  123,346  124,134  123,813  123,671 
    Financing lease right-of-use assets 75,083  75,462  76,574  76,958  77,343 
    Construction in progress —  —  40,421  35,101  31,978 
    Land held for development 57,535  57,203  49,110  52,408  52,408 
    Total real estate investments 10,292,596  10,391,060  11,168,747  11,794,629  11,810,710 
    Less accumulated depreciation and amortization (2,397,795) (2,381,297) (2,494,169) (2,583,819) (2,483,656)
    Total real estate investments, net 7,894,801  8,009,763  8,674,578  9,210,810  9,327,054 
    Cash and cash equivalents 26,172  43,345  25,507  25,722  68,916 
    Assets held for sale, net 143,580  604,747  358,207  6,635  12,897 
    Operating lease right-of-use assets 204,906  209,291  243,910  259,764  261,438 
    Investments in unconsolidated joint ventures 453,607  458,627  463,430  470,418  473,122 
    Other assets, net 487,795  533,874  469,940  522,920  507,496 
    Total assets$9,210,861 $9,859,647 $10,235,572 $10,496,269 $10,650,923 
          
    LIABILITIES, REDEEMABLE NON-CONTROLLING INTERESTS, AND STOCKHOLDERS' EQUITY     
     4Q 2025 3Q 2025 2Q 2025 1Q 2025 4Q 2024 
    Liabilities     
    Notes and bonds payable$3,911,423 $4,485,706 $4,694,391 $4,732,618 $4,662,771 
    Accounts payable and accrued liabilities 211,071  173,784  194,076  144,855  222,510 
    Liabilities of properties held for sale 15,160  69,808  30,278  422  1,283 
    Operating lease liabilities 162,922  166,231  203,678  224,117  224,499 
    Financing lease liabilities 73,130  72,654  73,019  72,585  72,346 
    Other liabilities 160,530  146,618  158,704  174,830  161,640 
    Total liabilities 4,534,236  5,114,801  5,354,146  5,349,427  5,345,049 
          
    Redeemable non-controlling interests 3,252  4,332  4,332  4,627  4,778 
          
    Stockholders' equity     
    Preferred stock, $0.01 par value; 200,000 shares authorized —  —  —  —  — 
    Common stock, $0.01 par value; 1,000,000 shares authorized 3,516  3,516  3,516  3,510  3,505 
    Additional paid-in capital 9,137,257  9,134,486  9,129,338  9,121,269  9,118,229 
    Accumulated other comprehensive (loss) income (5,174) (6,461) (9,185) (7,206) (1,168)
    Cumulative net income attributable to common stockholders 128,238  113,847  171,585  329,436  374,309 
    Cumulative dividends (4,646,944) (4,562,454) (4,477,940) (4,368,739) (4,260,014)
    Total stockholders' equity 4,616,893  4,682,934  4,817,314  5,078,270  5,234,861 
    Non-controlling interest 56,480  57,580  59,780  63,945  66,235 
    Total equity 4,673,373  4,740,514  4,877,094  5,142,215  5,301,096 
    Total liabilities, redeemable non-controlling interests, and stockholders' equity$9,210,861 $9,859,647 $10,235,572 $10,496,269 $10,650,923 
                    



    Statements of Income
    AMOUNTS IN THOUSANDS, EXCEPT PER SHARE DATA



          
     4Q 2025 3Q 2025 2Q 2025 1Q 2025 4Q 2024 
    Revenues     
    Rental income$274,731 $287,399 $287,070 $288,857 $300,065 
    Interest income 3,614  3,480  3,449  3,731  4,076 
    Other operating 7,958  6,886  6,983  6,389  5,625 
      286,303  297,765  297,502  298,977  309,766 
    Expenses     
    Property operating 110,732  113,456  109,924  114,963  114,415 
    General and administrative 13,787  21,771  23,482  13,530  34,208 
    Normalizing items1 (3,469) (12,046) (10,302) (502) (22,991)
    Normalized general and administrative 10,318  9,725  13,180  13,028  11,217 
    Transaction costs 300  125  593  1,011  1,577 
    Depreciation and amortization 127,408  137,841  147,749  150,969  160,330 
      252,227  273,193  281,748  280,473  310,530 
    Other income (expense)     
    Interest expense before merger-related fair value (37,337) (41,927) (42,766) (44,366) (47,951)
    Merger-related fair value adjustment (10,852) (10,715) (10,580) (10,446) (10,314)
    Interest expense (48,189) (52,642) (53,346) (54,812) (58,265)
    Gain on sales of real estate properties and other assets 135,711  76,771  20,004  2,904  32,082 
    Loss on extinguishment of debt (165) (286) —  —  (237)
    Impairment of real estate assets and credit loss reserves (105,806) (104,362) (142,348) (12,081) (81,098)
    Equity (loss) income from unconsolidated joint ventures (634) 287  158  1  224 
    Interest and other (expense) income, net (402) (2,884) (366) 95  (154)
      (19,485) (83,116) (175,898) (63,893) (107,448)
    Net income (loss)$14,591 $(58,544)$(160,144)$(45,389)$(108,212)
    Net (income) loss attributable to non-controlling interests (200) 806  2,293  516  1,366 
    Net income (loss) attributable to common stockholders$14,391 $(57,738)$(157,851)$(44,873)$(106,846)
          
          
    Basic earnings per common share$0.04 $(0.17)$(0.45)$(0.13)$(0.31)
    Diluted earnings per common share$0.04 $(0.17)$(0.45)$(0.13)$(0.31)
          
    Weighted average common shares outstanding - basic 350,052  349,964  349,628  349,539  351,560 
    Weighted average common shares outstanding - diluted2 350,052  349,964  349,628  349,539  351,560 
                    
    1. Normalizing items primarily include restructuring, severance-related costs and non-routine advisory fees associated with shareholder engagement.
    2. Potential common shares are not included in the computation of diluted earnings per share when a loss exists (or when dividends paid are greater than income), as the effect would be an antidilutive per share amount. As a result, the outstanding limited partnership units in the Company's operating partnership ("OP"), totaling 4,280,972 units were not included.



    FFO, Normalized FFO and FAD 1,2,3
    AMOUNTS IN THOUSANDS, EXCEPT PER SHARE DATA



          
     4Q 2025

     3Q 2025

     2Q 2025

     1Q 2025

     4Q 2024

     
    Net income (loss) attributable to common stockholders$14,391 $(57,738)$(157,851)$(44,873)$(106,846)
    Net income (loss) attributable to common stockholders/diluted share3$0.04 $(0.17)$(0.45)$(0.13)$(0.31)
          
    Gain on sales of real estate assets (135,711) (76,771) (20,004) (2,904) (32,082)
    Impairments of real estate assets 105,706  104,362  140,877  10,145  75,423 
    Real estate depreciation and amortization 134,736  143,187  152,936  155,288  164,656 
    Non-controlling income (loss) from operating partnership units 200  (806) (2,293) (599) (1,422)
    Unconsolidated JV depreciation, amortization and impairment 7,659  6,688  6,706  6,717  5,913 
    FFO adjustments$112,590 $176,660 $278,222 $168,647 $212,488 
    FFO adjustments per common share - diluted$0.32 $0.50 $0.79 $0.48 $0.60 
    NAREIT FFO$126,981 $118,922 $120,371 $123,774 $105,642 
    NAREIT FFO per common share - diluted$0.36 $0.34 $0.34 $0.35 $0.30 
          
    Transaction costs 300  125  593  1,011  1,577 
    Lease intangible amortization (698) (203) (222) (228) (2,348)
    Non-routine tax and legal matters (682) 9  478  77  306 
    Debt financing costs4 1,614  3,493  —  —  237 
    Restructuring and severance-related charges 3,469  12,046  10,302  502  22,991 
    Credit losses and (gains) losses on other assets, net 100  —  1,471  1,936  4,582 
    Merger-related fair value adjustment 10,852  10,715  10,580  10,446  10,314 
    Unconsolidated JV normalizing items5 211  233  163  204  113 
    Normalized FFO adjustments$15,166 $26,418 $23,365 $13,948 $37,772 
    Normalized FFO adjustments per common share - diluted$0.04 $0.07 $0.07 $0.04 $0.11 
    Normalized FFO$142,147 $145,340 $143,736 $137,722 $143,414 
    Normalized FFO per common share - diluted$0.40 $0.41 $0.41 $0.39 $0.40 
          
    Non-real estate depreciation and amortization 2,522  1,139  1,184  1,269  1,385 
    Non-cash interest amortization, net6 1,396  1,384  1,130  1,217  1,239 
    Rent reserves, net 582  146  130  94  (369)
    Straight-line amortization, net (6,554) (6,924) (8,022) (7,891) (8,032)
    Stock-based compensation 3,308  3,386  3,887  3,028  3,028 
    Unconsolidated JV non-cash items7 (348) (463) (356) (253) (277)
    Normalized FFO adjusted for non-cash items$143,053 $144,008 $141,689 $135,186 $140,388 
    2nd generation TI (11,120) (9,398) (12,036) (14,885) (20,003)
    Leasing commissions paid (7,645) (7,438) (5,187) (11,394) (11,957)
    Building capital (10,413) (10,319) (9,112) (6,687) (8,347)
    Total maintenance capex$(29,178)$(27,155)$(26,335)$(32,966)$(40,307)
    FAD$113,875 $116,853 $115,354 $102,220 $100,081 
    Quarterly dividends and OP distributions$85,506 $85,536 $110,486 $109,840 $110,808 
    FFO wtd avg common shares outstanding - diluted8 354,914  354,690  354,078  353,522  355,874 
                    
    1. Funds from operations ("FFO") and FFO per share are operating performance measures adopted by NAREIT. NAREIT defines FFO as "net income (computed in accordance with GAAP) excluding depreciation and amortization related to real estate, gains and losses from the sale of certain real estate assets, gains and losses from change in control, and impairment write-downs of certain real assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity."
    2. FFO, Normalized FFO and Funds Available for Distribution ("FAD") do not represent cash generated from operating activities determined in accordance with GAAP and are not necessarily indicative of cash available to fund cash needs. FFO, Normalized FFO and FAD should not be considered alternatives to net income attributable to common stockholders as indicators of the Company's operating performance or as alternatives to cash flow as measures of liquidity.
    3. Potential common shares are not included in the computation of diluted earnings per share when a loss exists (or when dividends paid are greater than income), as the effect would be an antidilutive per share amount.
    4. Includes loss on debt extinguishment, loss on derivatives, and legal fees related to the amended and restated credit facility.
    5. Includes the Company's proportionate share of normalizing items related to unconsolidated joint ventures such as lease intangibles and transaction costs.
    6. Includes the amortization of deferred financing costs, discounts and premiums, and non-cash financing receivable amortization.
    7. Includes the Company's proportionate share of straight-line rent, net and rent reserves, net related to unconsolidated joint ventures.
    8. The Company utilizes the treasury stock method, which includes the dilutive effect of nonvested share-based awards outstanding of 581,073 for the three months ended December 31, 2025. Also includes the diluted impact of 4,280,972 OP units outstanding.

     
    Reconciliation of Non-GAAP Measures
    DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA - UNAUDITED
     

    Management considers funds from operations ("FFO"), FFO per share, normalized FFO, normalized FFO per share, and funds available for distribution ("FAD") to be useful non-GAAP measures of the Company's operating performance. A non-GAAP financial measure is generally defined as one that purports to measure historical financial performance, financial position or cash flows, but excludes or includes amounts that would not be so adjusted in the most comparable measure determined in accordance with GAAP. Set forth below are descriptions of the non-GAAP financial measures management considers relevant to the Company's business and useful to investors.

    The non-GAAP financial measures presented herein are not necessarily identical to those presented by other real estate companies due to the fact that not all real estate companies use the same definitions. These measures should not be considered as alternatives to net income (determined in accordance with GAAP), as indicators of the Company's financial performance, or as alternatives to cash flow from operating activities (determined in accordance with GAAP) as measures of the Company's liquidity, nor are these measures necessarily indicative of sufficient cash flow to fund all of the Company's needs.

    FFO and FFO per share are operating performance measures adopted by the National Association of Real Estate Investment Trusts, Inc. ("NAREIT"). NAREIT defines FFO as "net income (computed in accordance with GAAP) excluding depreciation and amortization related to real estate, gains and losses from the sale of certain real estate assets, gains and losses from change in control, and impairment write-downs of certain real assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity." The Company defines Normalized FFO as FFO excluding acquisition-related expenses, lease intangible amortization and other normalizing items that are unusual and infrequent in nature. FAD is presented by adding to Normalized FFO non-real estate depreciation and amortization, deferred financing fees amortization, share-based compensation expense and rent reserves, net; and subtracting maintenance capital expenditures, including second generation tenant improvements and leasing commissions paid and straight-line rent income, net of expense. The Company's definition of these terms may not be comparable to that of other real estate companies as they may have different methodologies for computing these amounts. FFO, Normalized FFO and FAD do not represent cash generated from operating activities determined in accordance with GAAP and are not necessarily indicative of cash available to fund cash needs. FFO, Normalized FFO and FAD should not be considered an alternative to net income as an indicator of the Company's operating performance or as an alternative to cash flow as a measure of liquidity. FFO, Normalized FFO and FAD should be reviewed in connection with GAAP financial measures.

    Management believes FFO, FFO per share, Normalized FFO, Normalized FFO per share, and FAD provide an understanding of the operating performance of the Company's properties without giving effect to certain significant non-cash items, including depreciation and amortization expense. Historical cost accounting for real estate assets in accordance with GAAP assumes that the value of real estate assets diminishes predictably over time. However, real estate values instead have historically risen or fallen with market conditions. The Company believes that by excluding the effect of depreciation, amortization, gains or losses from sales of real estate, and other normalizing items that are unusual and infrequent, FFO, FFO per share, Normalized FFO, Normalized FFO per share and FAD can facilitate comparisons of operating performance between periods. The Company reports these measures because they have been observed by management to be the predominant measures used by the REIT industry and by industry analysts to evaluate REITs and because these measures are consistently reported, discussed, and compared by research analysts in their notes and publications about REITs.

    Cash NOI and Same Store Cash NOI are key performance indicators. Management considers these to be supplemental measures that allow investors, analysts and Company management to measure unlevered property-level operating results. The Company defines Cash NOI as rental income plus interest from financing receivables less property operating expenses. Cash NOI excludes non-cash items such as above and below market lease intangibles, straight-line rent, lease inducements, lease termination fees, financing receivable amortization, tenant improvement amortization and leasing commission amortization. Cash NOI is historical and not necessarily indicative of future results.

    Same Store Cash NOI compares Cash NOI for stabilized properties. Stabilized properties are properties that have been included in operations for the duration of the year-over-year comparison period presented. Accordingly, stabilized properties exclude properties that were recently acquired or disposed of, properties classified as held for sale, properties undergoing redevelopment, and newly redeveloped or developed properties.

    The Company utilizes the redevelopment classification for properties where management has approved a change in strategic direction through the application of additional resources, including an amount of capital expenditures significantly above routine maintenance and capital improvement expenditures.

    Any recently acquired property will be included in the same store pool once the Company has owned the property for five full quarters. Newly developed or redeveloped properties will be included in the same store pool five full quarters after substantial completion.

    Ron Hubbard

    Vice President, Investor Relations

    P: 615.269.8290



    Primary Logo

    Get the next $HR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HR

    DatePrice TargetRatingAnalyst
    10/20/2025$18.00Underweight → Equal Weight
    Wells Fargo
    10/8/2025$19.00Sector Perform
    RBC Capital Mkts
    10/1/2025$23.00Overweight
    Cantor Fitzgerald
    9/15/2025Mkt Perform → Underperform
    Raymond James
    9/5/2025$20.00Sector Perform → Sector Outperform
    Scotiabank
    1/2/2025$19.00 → $17.00Buy → Hold
    Jefferies
    1/2/2025$18.00 → $16.00Neutral → Underperform
    Wedbush
    12/20/2024$19.00Overweight → Neutral
    Analyst
    More analyst ratings

    $HR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP and CIO Crowley Ryan E. covered exercise/tax liability with 736 shares, decreasing direct ownership by 0.37% to 198,504 units (SEC Form 4)

    4 - Healthcare Realty Trust Inc (0001360604) (Issuer)

    2/17/26 4:36:28 PM ET
    $HR
    Real Estate Investment Trusts
    Real Estate

    EVP and CIO Crowley Ryan E. was granted 32,788 shares and covered exercise/tax liability with 3,873 shares, increasing direct ownership by 17% to 199,240 units (SEC Form 4)

    4 - Healthcare Realty Trust Inc (0001360604) (Issuer)

    2/11/26 6:05:54 PM ET
    $HR
    Real Estate Investment Trusts
    Real Estate

    EVP, General Counsel Loope Andrew Edward was granted 32,588 shares and covered exercise/tax liability with 6,574 shares, increasing direct ownership by 16% to 184,486 units (SEC Form 4)

    4 - Healthcare Realty Trust Inc (0001360604) (Issuer)

    2/11/26 6:04:08 PM ET
    $HR
    Real Estate Investment Trusts
    Real Estate

    $HR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Healthcare Realty Trust Announces $600 Million Commercial Paper Program

    NASHVILLE, Tenn., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) (the "Company") today announced the establishment of its inaugural commercial paper program. The program allows the Company's operating partnership, Healthcare Realty Holdings, L.P. (the "Issuer"), to issue up to $600 million of short-term, unsecured commercial paper notes. The notes will be sold under customary terms in the United States commercial paper note market and will rank pari passu with the Issuer's other senior unsecured indebtedness. The notes will be fully and unconditionally guaranteed by the Company. Note proceeds will be used for general corporate purposes. The notes and guar

    2/12/26 4:16:00 PM ET
    $HR
    Real Estate Investment Trusts
    Real Estate

    Healthcare Realty Reports Fourth Quarter 2025 Results

    NASHVILLE, Tenn., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the fourth quarter ended December 31, 2025 and introduced full year 2026 guidance. "2025 represented a transformational year for Healthcare Realty," commented Peter Scott, the Company's President and Chief Executive Officer. "Our operational team delivered same-store growth that continues to exceed historical levels while our transactions team exceeded targets with $1.2 billion in dispositions at attractive pricing levels. We are encouraged by secular long-term trends driving demand for outpatient medical services, tenant space and assets across the country. We ha

    2/12/26 4:15:00 PM ET
    $HR
    Real Estate Investment Trusts
    Real Estate

    Healthcare Realty Trust Announces Fourth Quarter Earnings Release Date and Conference Call

    NASHVILLE, Tenn., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced that on Thursday, February 12, 2026, after the market closes, it is scheduled to report results for the fourth quarter of 2025. On February 13, 2026, at 9:00 a.m. Eastern Time, Healthcare Realty Trust is scheduled to hold a conference call to discuss earnings results, quarterly activities, general operations of the Company and industry trends. Simultaneously, a webcast of the conference call will be available to interested parties at www.healthcarerealty.com under the Investor Relations section. A webcast replay will be available following the call at the same address. Confe

    1/20/26 8:00:00 PM ET
    $HR
    Real Estate Investment Trusts
    Real Estate

    $HR
    SEC Filings

    View All

    SEC Form 10-K filed by Healthcare Realty Trust Incorporated

    10-K - Healthcare Realty Trust Inc (0001360604) (Filer)

    2/13/26 4:16:40 PM ET
    $HR
    Real Estate Investment Trusts
    Real Estate

    Healthcare Realty Trust Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Healthcare Realty Trust Inc (0001360604) (Filer)

    2/12/26 4:17:41 PM ET
    $HR
    Real Estate Investment Trusts
    Real Estate

    SEC Form SCHEDULE 13G filed by Healthcare Realty Trust Incorporated

    SCHEDULE 13G - Healthcare Realty Trust Inc (0001360604) (Subject)

    2/9/26 6:36:20 AM ET
    $HR
    Real Estate Investment Trusts
    Real Estate

    $HR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Bohjalian Thomas N bought $164,600 worth of shares (10,000 units at $16.46), increasing direct ownership by 15% to 75,520 units (SEC Form 4)

    4 - Healthcare Realty Trust Inc (0001360604) (Issuer)

    8/13/25 5:01:59 PM ET
    $HR
    Real Estate Investment Trusts
    Real Estate

    Director Bohjalian Thomas N bought $36,775 worth of shares (2,500 units at $14.71), increasing direct ownership by 5% to 56,502 units (SEC Form 4)

    4 - Healthcare Realty Trust Inc (0001360604) (Issuer)

    5/14/25 8:59:20 AM ET
    $HR
    Real Estate Investment Trusts
    Real Estate

    Director Leupp Jay P bought $16,850 worth of shares (1,000 units at $16.85), increasing direct ownership by 3% to 33,830 units (SEC Form 4)

    4 - Healthcare Realty Trust Inc (0001360604) (Issuer)

    12/20/24 4:30:46 PM ET
    $HR
    Real Estate Investment Trusts
    Real Estate

    $HR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Healthcare Realty upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Healthcare Realty from Underweight to Equal Weight and set a new price target of $18.00

    10/20/25 8:23:32 AM ET
    $HR
    Real Estate Investment Trusts
    Real Estate

    RBC Capital Mkts initiated coverage on Healthcare Realty with a new price target

    RBC Capital Mkts initiated coverage of Healthcare Realty with a rating of Sector Perform and set a new price target of $19.00

    10/8/25 8:34:24 AM ET
    $HR
    Real Estate Investment Trusts
    Real Estate

    Cantor Fitzgerald initiated coverage on Healthcare Realty with a new price target

    Cantor Fitzgerald initiated coverage of Healthcare Realty with a rating of Overweight and set a new price target of $23.00

    10/1/25 8:52:41 AM ET
    $HR
    Real Estate Investment Trusts
    Real Estate

    $HR
    Leadership Updates

    Live Leadership Updates

    View All

    Healthcare Realty Announces Chief Financial Officer Transition

    NASHVILLE, Tenn., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) ("Healthcare Realty" or the "Company") today announced the appointment of Daniel Gabbay as Executive Vice President and Chief Financial Officer ("CFO"). He will be based at the Company's Nashville headquarters and assume his new role on January 12, 2026. Since 2024, Mr. Gabbay served as a Managing Director in the Real Estate Investment Banking Group of RBC Capital Markets ("RBC"), with primary coverage responsibility of the healthcare REIT sector. Prior to joining RBC, he served as a Managing Director in the Real Estate Investment Banking Group at Barclays. During his nearly 20-year career i

    1/7/26 4:15:00 PM ET
    $HR
    Real Estate Investment Trusts
    Real Estate

    SmartRent Appoints Thomas Bohjalian to Board of Directors

    Seasoned professional brings decades of real estate and finance industry experience SmartRent, Inc. (NYSE:SMRT), the leading provider of smart communities solutions and smart operations solutions for the rental housing industry, today announced the appointment of Thomas "Tom" Bohjalian to its Board of Directors. He will serve as a member of the Audit and Compensation Committees. Tom brings over 30 years of real estate and multifamily housing industry experience and public company governance to SmartRent's board. He currently serves as the board chair of Healthcare Realty Trust, Incorporated (NYSE:HR) and was previously on the board of directors for Apartment Income REIT Corporation (NYS

    6/24/25 8:00:00 AM ET
    $AIRC
    $CNS
    $HR
    Real Estate Investment Trusts
    Real Estate
    Investment Managers
    Finance

    Healthcare Realty Trust Announces CEO Transition

    Constance Moore appointed interim President and Chief Executive Officer, effective immediately Todd Meredith to step down Board intends to engage a leading executive search firm to help identify permanent successor NASHVILLE, Tenn., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) ("Healthcare Realty" or the "Company") today announced that Todd Meredith will step down as President and Chief Executive Officer ("CEO") and as a member of the Board of Directors ("board"), effective immediately. The board has appointed Constance "Connie" Moore, current Healthcare Realty board member and former President and CEO of BRE Properties, Inc., as interim President and

    11/12/24 6:45:00 AM ET
    $HR
    Real Estate Investment Trusts
    Real Estate

    $HR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Healthcare Realty Trust Incorporated

    SC 13D/A - Healthcare Realty Trust Inc (0001360604) (Subject)

    12/9/24 7:38:49 PM ET
    $HR
    Real Estate Investment Trusts
    Real Estate

    SEC Form SC 13D filed by Healthcare Realty Trust Incorporated

    SC 13D - Healthcare Realty Trust Inc (0001360604) (Subject)

    11/26/24 8:00:18 AM ET
    $HR
    Real Estate Investment Trusts
    Real Estate

    SEC Form SC 13G filed by Healthcare Realty Trust Incorporated

    SC 13G - Healthcare Realty Trust Inc (0001360604) (Subject)

    11/14/24 11:53:18 AM ET
    $HR
    Real Estate Investment Trusts
    Real Estate

    $HR
    Financials

    Live finance-specific insights

    View All

    Healthcare Realty Reports Fourth Quarter 2025 Results

    NASHVILLE, Tenn., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the fourth quarter ended December 31, 2025 and introduced full year 2026 guidance. "2025 represented a transformational year for Healthcare Realty," commented Peter Scott, the Company's President and Chief Executive Officer. "Our operational team delivered same-store growth that continues to exceed historical levels while our transactions team exceeded targets with $1.2 billion in dispositions at attractive pricing levels. We are encouraged by secular long-term trends driving demand for outpatient medical services, tenant space and assets across the country. We ha

    2/12/26 4:15:00 PM ET
    $HR
    Real Estate Investment Trusts
    Real Estate

    Healthcare Realty Trust Announces Fourth Quarter Earnings Release Date and Conference Call

    NASHVILLE, Tenn., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced that on Thursday, February 12, 2026, after the market closes, it is scheduled to report results for the fourth quarter of 2025. On February 13, 2026, at 9:00 a.m. Eastern Time, Healthcare Realty Trust is scheduled to hold a conference call to discuss earnings results, quarterly activities, general operations of the Company and industry trends. Simultaneously, a webcast of the conference call will be available to interested parties at www.healthcarerealty.com under the Investor Relations section. A webcast replay will be available following the call at the same address. Confe

    1/20/26 8:00:00 PM ET
    $HR
    Real Estate Investment Trusts
    Real Estate

    KBW Announces Index Rebalancing for Fourth-Quarter 2025

    NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Keefe, Bruyette & Woods, Inc., a leading specialist investment bank to the financial services and fintech sectors, and a wholly owned subsidiary of Stifel Financial Corp. (NYSE:SF), announces the upcoming index rebalancing for the fourth quarter of 2025. This quarter, there are constituent changes within six of our indexes: KBW Nasdaq Insurance Index (Index Ticker: KIX), KBW Nasdaq Regional Banking Index (Index Ticker: KRX, ETF Ticker: KBWR), KBW Nasdaq Financial Sector Dividend Yield Index (Index Ticker: KDX, ETF Ticker: KBWD), KBW Nasdaq Premium Yield Equity REIT Index (Index Ticker: KYX, ETF Ticker: KBWY), KBW Nasdaq Property and Casualty Ins

    12/12/25 8:30:00 PM ET
    $AAT
    $ACIW
    $AJG
    Real Estate Investment Trusts
    Real Estate
    Computer Software: Prepackaged Software
    Technology